Restricted accessResearch articleFirst published online 2018-6
Activation of the Wnt/β-Catenin Pathway by an Inflammatory Microenvironment Affects the Myogenic Differentiation Capacity of Human Laryngeal Mucosa Mesenchymal Stromal Cells
Various microenvironments influence the multiple differentiation potential of mesenchymal stromal cells. For example, inflammatory microenvironment can suppress the myogenic differentiation capability of laryngeal mucosa mesenchymal stromal cells (LM-MSCs). The present study therefore sought to identify the underlying molecular mechanisms regulating these processes. We isolated a novel population of MSCs, LM-MSCs, from the laryngeal mucosa tissues. The cells were cultured in osteogenic, adipogenic, and myogenic differentiation media in the presence or absence of interleukin-1β and tumor necrosis factor α (to simulate inflammatory microenvironment). The expression of active β-catenin, p-GSK3β, and GSK3β were detected by western blot and real-time polymerase chain reaction. The myogenic differentiation of LM-MSCs in inflammatory microenvironment and the regulation by Dickkopf-1 (DKK1) were tested both in vivo and in vitro. Inflammatory microenvironment could suppress the osteogenesis, adipogenesis, and myogenesis of LM-MSCs. The Wnt/β-catenin signaling pathway was activated during myogenesis in inflammatory microenvironment. The suppressed myogenic differentiation capability of LM-MSCs in inflammatory microenvironment was reversed by DKK1. By regulating the Wnt/β-catenin signaling pathway, DKK1 can improve the myogenic differentiation of LM-MSCs in inflammatory microenvironment. Thus, the results of this study may help improve the efficacy of LM-MSCs injection therapy for vocal fold regeneration.
Get full access to this article
View all access options for this article.
References
1.
ChenL, TredgetEE, WuPY and WuY. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One, 3:e1886.
2.
HermanS, KronkeG and SchettG. (2008). Molecular mechanisms of inflammatory bone damage: emerging targets for therapy. Trends Mol Med, 14:245–253.
3.
LanzoniG, RodaG, BelluzziA, RodaE and BagnaraGP. (2008). Inflammatory bowel disease: moving toward a stem cell-based therapy. World J Gastroenterol, 14:4616–4626.
4.
KanemaruS, NakamuraT, OmoriK, KojimaH, MagrufovA, HiratsukaY, HiranoS, ItoJ and ShimizuY. (2003). Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol, 112:915–920.
5.
HertegardS, CedervallJ, SvenssonB, ForsbergK, MaurerFH, VidovskaD, OliviusP, Ahrlund-RichterL and Le BlancK. (2006). Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection. Laryngoscope, 116:1248–1254.
6.
CedervallJ, Ahrlund-RichterL, SvenssonB, ForsgrenK, MaurerFH, VidovskaD and HertegardS. (2007). Injection of embryonic stem cells into scarred rabbit vocal folds enhances healing and improves viscoelasticity: short-term results. Laryngoscope, 117:2075–2081.
7.
LeeBJ, WangSG, LeeJC, JungJS, BaeYC, JeongHJ, KimHW and LorenzRR. (2006). The prevention of vocal fold scarring using autologous adipose tissue-derived stromal cells. Cells Tissues Organs, 184:198–204.
8.
PengH, MingL, YangR, LiuY, LiangY, ZhaoY, JinY and DengZ. (2013). The use of laryngeal mucosa mesenchymal stem cells for the repair the vocal fold injury. Biomaterials, 34:9026–9035.
9.
LaceyDC, SimmonsPJ, GravesSE and HamiltonJA. (2009). Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage, 17:735–742.
10.
LimX, TateyaI, TateyaT, Munoz-Del-RioA and BlessDM. (2006). Immediate inflammatory response and scar formation in wounded vocal folds. Ann Otol Rhinol Laryngol, 115:921–929.
11.
WehlingN, PalmerGD, PilapilC, LiuF, WellsJW, MullerPE, EvansCH and PorterRM. (2009). Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum, 60:801–812.
12.
LiGG, ZhuYT, XieHT, ChenSY and TsengSC. (2012). Mesenchymal stem cells derived from human limbal niche cells. Invest Ophthalmol Vis Sci, 53:5686–5697.
13.
CropMJ, BaanCC, KorevaarSS, IjzermansJN, PescatoriM, StubbsAP, van IjckenWF, DahlkeMH, EggenhoferE, WeimarW and HoogduijnMJ. (2010). Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol, 162:474–486.
14.
RattiganY, HsuJM, MishraPJ, GlodJ and BanerjeeD. (2010). Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res, 316:3417–3424.
15.
WideraD, MikenbergI, ElversM, KaltschmidtC and KaltschmidtB. (2006). Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling. BMC Neurosci, 7:64.
16.
RutherfordRB and GuK. (2000). Treatment of inflamed ferret dental pulps with recombinant bone morphogenetic protein-7. Eur J Oral Sci, 108:202–206.
17.
OrelioC, PeetersM, HaakE, van der HornK and DzierzakE. (2009). Interleukin-1 regulates hematopoietic progenitor and stem cells in the midgestation mouse fetal liver. Haematologica, 94:462–469.
18.
IosifRE, EkdahlCT, AhleniusH, PronkCJ, BondeS, KokaiaZ, JacobsenSE and LindvallO. (2006). Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci, 26:9703–9712.
19.
IosifRE, AhleniusH, EkdahlCT, DarsaliaV, ThoredP, JovingeS, KokaiaZ and LindvallO. (2008). Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1. J Cereb Blood Flow Metab, 28:1574–1587.
20.
BernardinoL, AgasseF, SilvaB, FerreiraR, GradeS and MalvaJO. (2008). Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells, 26:2361–2371.
21.
LoganCY and NusseR. (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol, 20:781–810.
22.
LingL, NurcombeV and CoolSM. (2009). Wnt signaling controls the fate of mesenchymal stem cells. Gene, 433:1–7.
23.
CleversH. (2006). Wnt/beta-catenin signaling in development and disease. Cell, 127:469–480.
24.
MacDonaldBT, TamaiK and HeX. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell, 17:9–26.
25.
SchaaleK, NeumannJ, SchneiderD, EhlersS and ReilingN. (2011). Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur J Cell Biol, 90:553–559.
26.
DugoL, CollinM and ThiemermannC. (2007). Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock, 27:113–123.
27.
LiuW, KonermannA, GuoT, JagerA, ZhangL and JinY. (2014). Canonical Wnt signaling differently modulates osteogenic differentiation of mesenchymal stem cells derived from bone marrow and from periodontal ligament under inflammatory conditions. Biochim Biophys Acta, 1840:1125–1134.
28.
LiuY, LiangQ, LiangYY and DengZH. (2011). [The isolation, cultivation and identification of laryngeal mucosal mesenchymal stem cells]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 46:408–412.
29.
Butler-BrowneGS, BarbetJP and ThornellLE. (1990). Myosin heavy and light chain expression during human skeletal muscle development and precocious muscle maturation induced by thyroid hormone. Anat Embryol (Berl), 181:513–522.
30.
ThornellLE, BilleterR, Butler-BrowneGS, ErikssonPO, RingqvistM and WhalenRG. (1984). Development of fiber types in human fetal muscle. An immunocytochemical study. J Neurol Sci, 66:107–115.
31.
MegeneyLA, KablarB, GarrettK, AndersonJE and RudnickiMA. (1996). MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev, 10:1173–1183.
32.
SealeP and RudnickiMA. (2000). A new look at the origin, function, and “stem-cell” status of muscle satellite cells. Dev Biol, 218:115–124.
33.
TapscottSJ, DavisRL, ThayerMJ, ChengPF, WeintraubH and LassarAB. (1988). MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science, 242:405–411.
34.
KongX, LiuY, YeR, ZhuB, ZhuY, LiuX, HuC, LuoH, ZhangY, DingY and JinY. (2013). GSK3beta is a checkpoint for TNF-alpha-mediated impaired osteogenic differentiation of mesenchymal stem cells in inflammatory microenvironments. Biochim Biophys Acta, 1830:5119–5129.
35.
GordonMD and NusseR. (2006). Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem, 281:22429–22433.
36.
BastianO, PillayJ, AlblasJ, LeenenL, KoendermanL and BlokhuisT. (2011). Systemic inflammation and fracture healing. J Leukoc Biol, 89:669–673.
37.
BhandariM, TornettaP3rd, SpragueS, NajibiS, PetrisorB, GriffithL and GuyattGH. (2003). Predictors of reoperation following operative management of fractures of the tibial shaft. J Orthop Trauma, 17:353–361.
38.
ReikerasO, ShegarfiH, WangJE and UtvagSE. (2005). Lipopolysaccharide impairs fracture healing: an experimental study in rats. Acta Orthop, 76:749–753.
39.
GilbertL, HeX, FarmerP, RubinJ, DrissiH, van WijnenAJ, LianJB, SteinGS and NanesMS. (2002). Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem, 277:2695–2701.
40.
WeitzmannMN, RoggiaC, ToraldoG, WeitzmannL and PacificiR. (2002). Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest, 110:1643–1650.
ChoHH, KimYJ, KimSJ, KimJH, BaeYC, BaB and JungJS. (2006). Endogenous Wnt signaling promotes proliferation and suppresses osteogenic differentiation in human adipose derived stromal cells. Tissue Eng, 12:111–121.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
